IP Library Granted Patent US 8,133,689
Granted Patent B2
US 8,133,689 · App. 13/176,983 · Granted Mar 13, 2012

Members of the capsaicin/vanilloid receptor family of proteins and uses thereof

Assignee: Bayer Schering Pharma Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,689
App. No.
13/176,983
Granted
Mar 13, 2012
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Claims (18)

1. A method for identifying a compound which binds to a polypeptide comprising the amino acid sequence of SEQ ID NO:2, the method comprising:

a) contacting a sample comprising the polypeptide with a test compound under conditions suitable for binding; and

b) determining whether the test compound binds to the polypeptide, thereby identifying a compound which binds to a polypeptide comprising the amino acid sequence of SEQ ID NO:2.

2. The method of claim 1 wherein the polypeptide consists of SEQ ID NO:2.

3. The method of claim 1 wherein the sample is a cell.

4. The method of claim 1 , wherein the polypeptide is isolated.

5. The method of claim 1 wherein the sample comprises a membrane-bound form of the polypeptide.

6. The method of claim 1 wherein binding of the test compound to the polypeptide is detected by the use of a direct binding assay.

7. The method of claim 1 wherein binding of the test compound to the polypeptide is detected by the use of a competition binding assay.

8. The method of claim 1 wherein binding of the test compound to the polypeptide is detected by the use of an assay for hVR-1 activity.

9. The method of claim 8 wherein the assay comprises:

(a) measuring in a first cell a first rapid inactivating inward current in the absence of a test compound;

(b) measuring in a second cell a second rapid inactivating inward current in the presence of the test compound, wherein the first and second rapid inactivating inward currents are stimulated by a temperature of 48-50° C. and wherein the first and second cells express the polypeptide comprising the amino acid sequence SEQ ID NO:2; and

(c) comparing the first and second rapid inactivating inward currents, wherein a difference between the first and second rapid inactivating inward currents identifies the test compound as a compound which modulates the activity of the polypeptide.

10. The method of claim 8 , wherein the hVR-1 activity is modulation of membrane depolarization.

11. The method of claim 8 , wherein the hVR-1 activity is modulation of intracellular calcium levels.

12. The method of claim 3 , wherein the cell is a neuronal cell.

13. The method of claim 9 wherein the first and second cells are neuronal cells.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2011
From: CURTIS, RORY A. J.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 026606/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2011
From: MILLENNIUM PHARMACEUTICALS, INC.
To: BAYER HEALTHCARE AG
Reel/Frame 026606/0696 →
MERGER Recorded Jul 18, 2011
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 026609/0765 →
Continuity (10)
Division 12895052 · Sep 30, 2010
Division 11967558 · Dec 31, 2007
Continuation 11013090 · Dec 15, 2004
Division 09587111 · Jun 2, 2000
Division 09439165 · Nov 12, 1999
Continuation In Part 09421134 · Oct 19, 1999
Continuation In Part 09258633 · Feb 26, 1999
Provisional Application 60114078 · Dec 28, 1998
Provisional Application 60108322 · Nov 13, 1998
Related Publication 20110300560A1 · Dec 8, 2011